Former pharma executives. Bespoke market entry strategies. Every engagement protected by professional liability insurance coverage that neither consultant nor client can access elsewhere.
J.D. Insurance occupies a unique position in the pharmaceutical industry: we are simultaneously an institutional insurer with 40 years of healthcare expertise and a business development advisory practice staffed by former C-suite and VP-level executives from global pharmaceutical companies.
Every J.D. business development engagement combines the strategic depth of executives who have personally executed market entries, licensing deals, and M&A transactions with insurance protection that covers the outcome of that advice. If our guidance leads to a measurable advisory failure, our policy responds. This is a commitment no conventional consulting firm can make.
Six service lines staffed by former industry executives. All engagements are insured from the first deliverable.
New market feasibility analysis, regulatory pathway assessment, distribution structure design, and go-to-market sequencing. Delivered by executives who have personally launched products in your target markets.
Comprehensive vetting and due diligence on distribution partners, including financial health, regulatory track record, market reach, and compliance posture. Full contract negotiation support with our legal network.
In-licensing, out-licensing, and co-promotion agreement structuring and negotiation. Valuation modeling, term sheet preparation, and regulatory affairs alignment for every deal structure.
Pharmaceutical acquisition target identification, scientific and commercial due diligence, pipeline valuation, and integration planning. Staffed by former BD heads from major pharmaceutical companies.
Joint venture framework design, co-development agreement structuring, and co-commercialization arrangements. Governance design, IP protection, and exit mechanism planning for every partnership structure.
Direct access to former pharma C-suite and VP-level business development professionals for client engagements, board-level advisory, and high-stakes negotiation support. Available to J.D. policyholders exclusively.
Our BD principals have spent careers inside global pharmaceutical companies – not consulting from the outside.
North America, Europe, Middle East, Asia-Pacific, Latin America, Sub-Saharan Africa.
Our business development consultants are former VP-level and C-suite executives from global pharmaceutical companies. They bring direct experience in regulatory affairs, licensing, M&A, and international market entry – not theoretical frameworks.
They have personally negotiated multi-hundred-million-dollar licensing agreements, led acquisition due diligence for global pharma buyers, launched products in emerging markets without established distribution infrastructure, and managed the regulatory complexity of multi-jurisdiction simultaneous launches. That operational depth is what J.D. puts in the room for every client engagement.
What separates J.D. from every other pharmaceutical advisory firm is not the caliber of our executives – it is the fact that our advice is backed by institutional insurance capacity.
"Unlike a conventional consulting firm, every J.D. business development engagement carries professional liability insurance coverage that protects both the consultant and the client against advisory failures."
Conventional consulting firms provide advice and disclaimers. J.D. provides advice, accountability, and insurance – a combination that changes the nature of the advisory relationship entirely. When our market entry recommendation fails, our policy responds. That alignment of incentives is fundamental to how we operate.
Errors and omissions coverage for all advisory deliverables including market entry recommendations, distribution partner assessments, and licensing negotiation support.
Protection against quantifiable revenue losses arising from failed market entry strategies executed in accordance with J.D. advisory deliverables.
Errors and omissions coverage specific to M&A advisory work, including due diligence failures, valuation errors, and deal structuring mistakes.
A structured engagement framework that aligns advisory work with insurance coverage at each stage – ensuring protection is in place before execution begins.
Scope of work definition, executive team assignment, and insurance coverage design. Coverage attaches to the engagement from day one.
Competitive landscape analysis, regulatory pathway evaluation, distribution infrastructure assessment, and preliminary financial modeling for target markets.
Market entry strategy, partner identification, deal structure design, and sequencing recommendations. All deliverables covered by professional liability from point of delivery.
Partner negotiations, regulatory filing support, commercial launch preparation, and distribution agreement finalization. Active J.D. executive participation throughout.
Formal documentation of advisory deliverables against which professional liability coverage attaches. Coverage reviewed and confirmed at each execution milestone.
Post-launch performance tracking against projections. Coverage remains active through the defined outcome monitoring period established at engagement initiation.
All business development engagements begin with a confidential strategic conversation at the executive level. No boilerplate assessments.
Corporate Inquiry →